SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wall Brett A.

(Last) (First) (Middle)
710 MEDTRONIC PARKWAY
LC300

(Street)
MINNEAPOLIS MN 55432

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2019
3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Group Pres Restora Thera
5. If Amendment, Date of Original Filed (Month/Day/Year)
11/07/2019
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 13,175(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 10/28/2020(2) 10/28/2029 Ordinary Shares 22,579 106.22 D
Stock Option (Right to Buy) 08/03/2016(2) 08/03/2025 Ordinary Shares 11,154 78 D
Stock Option (Right to Buy) 08/03/2016(2) 08/03/2025 Ordinary Shares 1,283 78 D
Stock Option (Right to Buy) 08/01/2017(2) 08/01/2026 Ordinary Shares 11,356 88.06 D
Stock Option (Right to Buy) 08/01/2017(2) 08/01/2026 Ordinary Shares 1,136 88.06 D
Stock Option (Right to Buy) 07/31/2018(2) 07/31/2027 Ordinary Shares 11,910 83.97 D
Stock Option (Right to Buy) 07/31/2018(2) 07/31/2027 Ordinary Shares 1,191 83.97 D
Stock Option (Right to Buy) 07/30/2019(2) 07/30/2028 Ordinary Shares 16,946 89.08 D
Stock Option (Right to Buy) 07/30/2019(2) 07/30/2028 Ordinary Shares 1,695 89.08 D
Stock Option (Right to Buy) 07/29/2020(2) 07/29/2029 Ordinary Shares 24,223 103.26 D
Stock Option (Right to Buy) 07/29/2020(2) 07/29/2029 Ordinary Shares 1,615 103.26 D
Stock Option (Right to Buy) 12/02/2014(2) 12/01/2023 Ordinary Shares 12,300 47 D
Stock Option (Right to Buy) 06/29/2018(3) 01/27/2025 Ordinary Shares 8,018 74.84 D
Explanation of Responses:
1. The number of shares beneficially owned includes 100 ordinary shares that were inadvertently omitted from Mr. Wall's previous filing.
2. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
3. This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.
/s/ Perry F. Sekus, attorney-in-fact 01/06/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.